Dr. Reddys Laboratories Ltd.

Dr Reddy's Laboratories, has launched Zoledronic Acid Injection (4mg/5ml), a bioequivalent generic version of Zometa (zoledronic acid) 4 mg/5ml injection in the US market on March 4, 2012, following the approval by the United States Food & Drug Administration (USFDA) of the company's ANDA for Zoledronic acid injection (4 mg/5ml). The company’s Zoledronic Acid Injection 4mg/5ml is available in a single use vial of concentrate.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.